Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHA₂DS₂-VAS_c Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism

References

• Kodani E, Atarashi H, Inoue H, et al. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry. Eur Heart J Qual Care Clin Outcomes. 2018;4(1):59–68. doi:10.1093/ehjqcco/qcx032
   PubMed Web of Science ®Google Scholar
• Antit S, Hamraoui N, Boussabeh I, et al. Atrial fibrillation in the elderly: therapy and prognosis characteristics. Arch Cardiovasc Dis Sup. 2021;13(1):97.
   Google Scholar
• Wang L, Feng Z, Li J, et al. Trends of global burden of atrial fibrillation/flutter from global burden of disease study 2017. Heart. 2020;107(11):881–887. doi:10.1136/heartjnl-2020-317656
   PubMed Web of Science ®Google Scholar
• Du X, Dong J, Ma C. Is atrial fibrillation a preventable disease? J Am Coll Cardiol. 2017;69(15):1968–1982. doi:10.1016/j.jacc.2017.02.020
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. doi:10.1161/CIR.0000000000000659
   PubMed Web of Science ®Google Scholar
• Liu X, Li XW. Research progress of rivaroxaban in anticoagulant therapy for non-valvular atrial fibrillation. China Med. 2019;9(12):1913–1916.
   Google Scholar
• Arboix A, Alio J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150–161. doi:10.2174/157340310791658730
   PubMedGoogle Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Yesin M, Kalcik M, Cagdas M, et al. Fragmented QRS may predict new onset atrial fibrillation in patients with ST-segment elevation myocardial infarction. J Electrocardiol. 2018;51(1):27–32. doi:10.1016/j.jelectrocard.2017.08.014
   PubMed Web of Science ®Google Scholar
• Karakayali M, Artac I, Omar T, et al. Assessment of the efficacy of the electrocardiographic P-wave peak time in predicting atrial high rate episode in patients with cardiac implantable electronic devices. J Electrocardiol. 2023;80:40–44. doi:10.1016/j.jelectrocard.2023.05.001
   PubMed Web of Science ®Google Scholar
• Hu WS, Lin CL. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Europace. 2018;20(4):575–581. doi:10.1093/europace/eux065
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220. doi:10.1161/CIR.0b013e31823ac046
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019;16(8):e66–e93. doi:10.1016/j.hrthm.2019.01.024
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–2870. doi:10.1001/jama.285.22.2864
   PubMed Web of Science ®Google Scholar
• Jia XM, Levine GN, Birnbaum Y, et al. The CHA2DS2-VASc score: not as simple as it seems. Int J Cardiol. 2018;257:92–96. doi:10.1016/j.ijcard.2017.12.027
   PubMed Web of Science ®Google Scholar
• Renda G, Ricci F, Patti G, et al. CHA(2)DS(2)VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation. Eur J Prev Cardiol. 2019;26(18):1987–1997. doi:10.1177/2047487319868320
   PubMed Web of Science ®Google Scholar
• Tateishi Y, Tsujino A, Hamabe J, et al. Cardiac diastolic dysfunction predicts in-hospital mortality in acute ischemic stroke with atrial fibrillation. J Neurol Sci. 2014;345(1–2):83–86. doi:10.1016/j.jns.2014.07.011
   PubMed Web of Science ®Google Scholar
• Kim T-H, Shim CY, Park JH. Left ventricular diastolic dysfunction is associated with atrial remodeling and risk or presence of stroke in patients with paroxysmal atrial fibrillation. J Cardiol. 2016;68(2):104–109. doi:10.1016/j.jjcc.2015.10.008
   PubMed Web of Science ®Google Scholar
• Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26(20):2083–2092. doi:10.1093/eurheartj/ehi350
   PubMed Web of Science ®Google Scholar
• Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243. doi:10.1038/nrcardio.2015.2
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhao J, Gong Y, et al. Autophagy exacerbates electrical remodeling in atrial fibrillation by ubiquitin-dependent degradation of L-type calcium channel. Cell Death Dis. 2018;9(9):873. doi:10.1038/s41419-018-0860-y
   PubMed Web of Science ®Google Scholar
• Ozbeyaz NB, Gokalp G, Algul E, et al. H(2)FPEF score and contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Angiology. 2023;74(2):181–188. doi:10.1177/00033197221099425
   PubMed Web of Science ®Google Scholar
• Ozbeyaz NB, Gokalp G, Algul E, et al. Platelet-hemoglobin ratio predicts amputation in patients with below-knee peripheral arterial disease. BMC Cardiovasc Disord. 2022;22(1):337. doi:10.1186/s12872-022-02788-2
   PubMed Web of Science ®Google Scholar
• Ozbeyaz NB, Gokalp G, Gezer AE, et al. Novel marker for predicting the severity and prognosis of acute pulmonary embolism: platelet-to-hemoglobin ratio. Biomark Med. 2022;16(12):915–924. doi:10.2217/bmm-2022-0201
   PubMed Web of Science ®Google Scholar
• Chen C, Gu L, Chen L, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential predictors of prognosis in acute ischemic stroke. Front Neurol. 2020;11:525621. doi:10.3389/fneur.2020.525621
   PubMed Web of Science ®Google Scholar
• Gary T, Pichler M, Belaj K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8(7):e67688. doi:10.1371/journal.pone.0067688
   PubMed Web of Science ®Google Scholar
• Guan Y-Z, Yin R-X, Zheng P-F, Liu C-X, Wei B-L, Deng G-X. Association of RDW, NLR, and PLR with atrial fibrillation in critical care patients: a retrospective study based on propensity score matching. Dis Markers. 2022;2022:2694499. doi:10.1155/2022/2694499
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Wachowicz B. Platelet haemostatic function in psychiatric disorders: effects of antidepressants and antipsychotic drugs. World J Biol Psychiatry. 2017;18(8):564–574. doi:10.3109/15622975.2016.1155748
   PubMed Web of Science ®Google Scholar
• Stegner D, Klaus V, Nieswandt B. Platelets as modulators of cerebral ischemia/reperfusion Injury. Front Immunol. 2019;10:2505. doi:10.3389/fimmu.2019.02505
   PubMed Web of Science ®Google Scholar
• Jayaraj RL, Azimullah S, Beiram R, et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. doi:10.1186/s12974-019-1516-2
   PubMed Web of Science ®Google Scholar
• Rivera-Caravaca JM, Roldan V, Esteve-Pastor MA, et al. Prediction of long-term net clinical outcomes using the TIMI-AF score: comparison with CHA(2)DS(2)-VASc and HAS-BLED. Am Heart J. 2018;197:27–34. doi:10.1016/j.ahj.2017.11.004
   PubMed Web of Science ®Google Scholar
• Costello M, Murphy R, Judge C, et al. Effect of non-vitamin-K oral anticoagulants on stroke severity compared to warfarin: a meta-analysis of randomized controlled trials. Eur J Neurol. 2020;27(3):413–418. doi:10.1111/ene.14134
   PubMed Web of Science ®Google Scholar
• Milentijevic D, Lin JH, Connolly N, et al. Risk of stroke outcomes in atrial fibrillation patients treated with rivaroxaban and warfarin. J Stroke Cerebrovasc Dis. 2021;30(5):105715. doi:10.1016/j.jstrokecerebrovasdis.2021.105715
   PubMed Web of Science ®Google Scholar